Chemed [CHE] vs Amedisys [AMED] Detailed Stock Comparison

Chemed Corporation

NYSE
Loading...

Amedisys Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Chemed Corporation wins in 15 metrics, Amedisys Inc. wins in 5 metrics, with 0 ties. Chemed Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Chemed Corporation Amedisys Inc. Better
P/E Ratio (TTM) 20.88 39.30 Chemed Corporation
Price-to-Book Ratio 5.36 2.69 Amedisys Inc.
Debt-to-Equity Ratio 14.68 35.34 Chemed Corporation
PEG Ratio -2.12 -2.78 Chemed Corporation
EV/EBITDA 13.21 13.74 Chemed Corporation
Profit Margin (TTM) 10.48% 3.56% Chemed Corporation
Operating Margin (TTM) 16.62% 11.70% Chemed Corporation
EBITDA Margin (TTM) 16.62% 11.70% Chemed Corporation
Return on Equity 25.28% 6.67% Chemed Corporation
Return on Assets (TTM) 13.40% 6.52% Chemed Corporation
Free Cash Flow (TTM) $325.48M $214.29M Chemed Corporation
Dividend Yield 0.56% N/A N/A
1-Year Return -23.92% 2.68% Amedisys Inc.
Price-to-Sales Ratio (TTM) 2.03 1.38 Amedisys Inc.
Enterprise Value $5.34B $3.48B Chemed Corporation
EV/Revenue Ratio 2.11 1.45 Amedisys Inc.
Gross Profit Margin (TTM) 35.22% 43.96% Amedisys Inc.
Revenue per Share (TTM) $176 $73 Chemed Corporation
Earnings per Share (Diluted) $18.34 $2.57 Chemed Corporation
Beta (Stock Volatility) 0.48 0.90 Chemed Corporation
Short % of Float 4.26% 9.90% Chemed Corporation

Chemed Corporation vs Amedisys Inc. Stock Performance Analysis

Loading Price Chart...

CHE
AMED

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Chemed Corporation1.00%-3.56%-2.54%6.32%-1.61%-0.07%
Amedisys Inc.0.00%0.05%3.57%7.76%10.13%10.13%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Chemed Corporation-23.92%-23.30%-10.84%220.84%546.58%704.20%
Amedisys Inc.2.68%-14.45%-58.43%149.36%328.29%215.59%

Performance & Financial Health Analysis: Chemed Corporation vs Amedisys Inc.

MetricCHEAMED
Market Information
Market Cap i$5.65B$3.32B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i222,0261,027,642
90 Day Avg. Volume i264,265618,767
Last Close$423.49$100.99
52 Week Range$365.21 - $562.77$82.15 - $101.02
% from 52W High-24.75%-0.03%
All-Time High$654.62 (Mar 11, 2024)$325.12 (Jan 25, 2021)
% from All-Time High-35.31%-68.94%
Growth Metrics
Quarterly Revenue Growth0.00%0.05%
Quarterly Earnings Growth-0.15%-0.13%
Financial Health
Profit Margin (TTM) i0.10%0.04%
Operating Margin (TTM) i0.17%0.12%
Return on Equity (TTM) i0.25%0.07%
Debt to Equity (MRQ) i14.6835.34
Cash & Liquidity
Book Value per Share (MRQ)$71.44$37.48
Cash per Share (MRQ)$5.41$10.26
Operating Cash Flow (TTM) i$388.27M$239.42M
Levered Free Cash Flow (TTM) i$246.01M$300.69M
Dividends
Last 12-Month Dividend Yield i0.56%N/A
Last 12-Month Dividend i$2.30N/A

Valuation & Enterprise Metrics Analysis: Chemed Corporation vs Amedisys Inc.

MetricCHE (Apr 26, 2026)AMED (Aug 31, 2025)
Price Ratios
P/E Ratio (TTM) i20.8839.30
Forward P/E i14.3919.76
PEG Ratio i-2.12-2.78
Price to Sales (TTM) i2.031.38
Price to Book (MRQ) i5.362.69
Market Capitalization
Market Capitalization i$5.65B$3.32B
Enterprise Value i$5.34B$3.48B
Enterprise Value Metrics
Enterprise to Revenue i2.111.45
Enterprise to EBITDA i13.2113.74
Risk & Other Metrics
Beta i0.480.90
Book Value per Share (MRQ) i$71.44$37.48

Financial Statements Comparison: Chemed Corporation vs Amedisys Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCHE (2025)AMED (2024)
Revenue/Sales i2.53B2.35B
Cost of Goods Sold i1.71B1.33B
COGS % of Revenue i67.5%56.7%
Gross Profit i823.18M1.02B
Gross Margin i32.5%43.3%
Research & Development iN/AN/A
Operating Income (EBIT) i341.16M209.57M
Operating Margin i13.5%8.9%
EBITDA i425.28M292.47M
EBITDA Margin i16.8%12.5%
Pre-Tax Income i355.78M86.22M
Pre-Tax Income % of Revenue i14.1%3.7%
Income Tax i90.54M48.05M
Income Tax % of Revenue i3.6%2.0%
Net Income (Profit) i265.24M38.16M
Profit Margin i10.5%1.6%

Balance Sheet & Liquidity Metrics

MetricCHE (2025)AMED (2024)
Cash & Equivalents i74.52M303.24M
Total Current Assets i302.62M632.08M
Total Current Assets % of Revenue i12.0%26.9%
Total Current Liabilities i287.13M514.39M
Total Current Liabilities % of Revenue i11.3%21.9%
Long-Term Debt i102.87M395.42M
Long-Term Debt % of Revenue i4.1%16.8%
Total Shareholders Equity i979.41M1.18B
Retained Earnings i2.96B791.16M
Retained Earnings % of Revenue i116.8%33.7%
Property, Plant & Equipment i131.15M167.80M

Cash Flow Statement Comparison

MetricCHE (2025)AMED (2024)
Operating Cash Flow i383.11M144.50M
Operating Cash Flow % of Revenue i15.1%6.2%
Capital Expenditures i4.57M-6.55M
Free Cash Flow i325.48M214.29M
FCF Margin i12.9%9.1%
Debt Repayment i00
Common Stock Repurchase i-431.50M-6.15M

Short Interest & Institutional Ownership Analysis

MetricCHEAMED
Shares Short i487,8633.20M
Short Ratio i1.626.84
Short % of Float i4.26%9.90%
Shares Outstanding i13.71M32.78M
Float Shares i13.53M32.24M
% Held by Insiders i1.87%1.95%
% Held by Institutions i98.39%96.37%
% Held by Public i-0.26%1.68%

Dividend Analysis & Yield Comparison: Chemed Corporation vs Amedisys Inc.

MetricCHEAMED
Last 12-Month Dividend i$2.30N/A
Last 12-Month Dividend Yield i0.56%N/A
3-Year Avg Annual Dividend i$1.93N/A
3-Year Avg Dividend Yield i0.09%N/A
3-Year Total Dividends i$5.78N/A
Ex-Dividend DateFeb 23, 2026N/A